Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor underlying update to the page. The visible study details and layout remain unchanged.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating an updated revision history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page adds a recruitment-status note indicating no longer looking for participants and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting to a different style.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page shows Revision: v3.5.5 instead of v3.5.4, indicating a software version update with no evident changes to the study details.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a deployment/patch to the ClinicalTrials.gov interface rather than changes to the study content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s display/version marker was updated from v3.5.2 to v3.5.3, indicating a site release change rather than any modification to the study record.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.